Welcome: Chemsynlab ,carbohydrate chemistry
Language: Chinese ∷  English

181225-33-2 , Ginsenoside Rg4

181225-33-2 , Ginsenoside Rg4 ,
20(Z)-Ginsenoside F4
Cas:181225-33-2
C42H70O12 / 767.00
MFCD22200428

Ginsenoside Rg4 , 20(Z)-Ginsenoside F4

(E)-Ginsenoside F4 is a ginseng saponin that has been shown to inhibit the phosphorylation of inflammatory cytokines, such as TNF-α and IL-1β. It also inhibits the production of inflammatory mediators in immune cells, such as prostaglandin E2, reactive oxygen species, and nitric oxide. Ginsenoside F4 has been shown to be effective in inhibiting prostate cancer cell growth and inducing apoptosis. This saponin is an ingredient in traditional Chinese medicine preparations for treating muscle diseases and other inflammatory diseases.

Ginsenoside RG4 is a compound that has been identified as one of the crucial bioactive components of Panax ginseng, commonly known as Korean ginseng. This compound has been reported to have various pharmacological properties that have been attributed to the many benefits that ginseng is known for. Ginsenoside RG4, in particular, has been found to have potent and exciting biological activities, which have made it a subject of interest in scientific research. This paper will provide an in-depth analysis of ginsenoside RG4, focusing on its definition and background, physical and chemical properties, synthesis and characterization, analytical methods, biological properties, toxicity and safety in scientific experiments, applications in scientific experiments, current state of research, potential implications in various fields of research and industry, and limitations and future directions.

Definition and Background

Ginsenosides are a group of triterpenoid saponins that are found predominantly in Panax species such as P. ginseng, P. quinquefolium, and P. notoginseng. These compounds are considered to be the primary bioactive constituents of ginseng and have been reported to have various pharmacological properties such as anti-tumor, anti-inflammatory, immunomodulatory, and neuroprotective activities. Ginsenoside RG4 is one of the rare ginsenosides found in Panax species, and it has been isolated from the roots of P. ginseng.

Synthesis and Characterization

Ginsenoside RG4 can be synthesized from protopanaxadiol-type ginsenosides such as ginsenoside Rb1, which is abundant in P. ginseng. The synthesis process involves using mild acidic conditions to transform ginsenoside Rb1 into ginsenoside Rg3, which is then further transformed into ginsenoside Rh2. Finally, ginsenoside Rh2 is converted into ginsenoside RG4 by hydrogenation under alkaline conditions. Ginsenoside RG4 can be characterized using various analytical techniques such as high-performance liquid chromatography, mass spectrometry, and nuclear magnetic resonance.

Analytical Methods

High-performance liquid chromatography (HPLC) is a commonly used analytical technique for the analysis of ginsenosides, including ginsenoside RG4. HPLC separates the various ginsenosides based on their physicochemical properties, such as polarity, size, and charge. Mass spectrometry (MS) is utilized for the precise measurement of the molecular weight and elemental composition of ginsenoside RG4. Nuclear magnetic resonance (NMR) spectroscopy is used to determine the structural and chemical properties of ginsenoside RG4.

Biological Properties

Ginsenoside RG4 has been reported to have various biological activities such as anti-tumor, anti-inflammatory, immunomodulatory, and neuroprotective activities. It has been found to inhibit the growth and proliferation of various cancer cells, including breast cancer, liver cancer, prostate cancer, and lung cancer. Ginsenoside RG4 has also been shown to have anti-inflammatory effects by decreasing the production of pro-inflammatory cytokines. Additionally, ginsenoside RG4 has been found to enhance the immune system by increasing the production of immune cells such as T-cells and natural killer cells. It has also been found to have neuroprotective effects by reducing oxidative stress and inflammation in the brain.

Toxicity and Safety in Scientific Experiments

Studies have suggested that ginsenoside RG4 is a relatively safe compound with low toxicity. While higher doses of ginsenoside RG4 have been reported to cause gastrointestinal disorders, no severe adverse effects have been reported in scientific experiments.

Applications in Scientific Experiments

Ginsenoside RG4 has been utilized in scientific experiments as a potential therapeutic agent for various conditions such as cancer, inflammation, and neurological disorders. It has been used to inhibit the growth and proliferation of cancer cells, reduce inflammation, and protect against neurodegeneration.

Current State of Research

Current research on ginsenoside RG4 is still in its early stages, but there is immense interest in its potential therapeutic applications. Studies have shown promising results regarding its pharmacological properties, and more research is being conducted to determine its efficacy and safety.

Potential Implications in Various Fields of Research and Industry

The potential implications of ginsenoside RG4 in various fields of research and industry are vast. Ginsenoside RG4 has the potential to be developed into a therapeutic agent for various conditions such as cancer, inflammation, and neurological disorders. It could also be utilized as an ingredient in functional foods and nutraceuticals.

Limitations and Future Directions

One of the major limitations of ginsenoside RG4 is its low bioavailability, which limits its therapeutic efficacy. Future research could focus on developing more efficient delivery methods to increase its bioavailability. Additionally, more studies could be conducted to determine its efficacy in treating various conditions and its potential adverse effects in the long term.

Future Directions

1. Development of more efficient delivery methods of ginsenoside RG4 to increase its bioavailability.

2. Investigation of the safety and efficacy of ginsenoside RG4 in long-term use.

3. Development of ginsenoside RG4 derivatives with improved pharmacological properties.

4. Study of the potential interaction of ginsenoside RG4 with other medications.

5. Exploration of the use of ginsenoside RG4 in combination therapy with other compounds or drugs.

6. Investigation of the role of ginsenoside RG4 in regulating immune function or enhancing immune responses.

7. Examination of the potential effects of ginsenoside RG4 on gut microbiota and gut health.

8. Exploration of the role of ginsenoside RG4 in neuroprotection and the treatment of neurodegenerative disorders.

9. Investigation of the antidiabetic effects of ginsenoside RG4 and its potential as a therapeutic agent for diabetes.

10. Study of the potential anticancer effects of ginsenoside RG4 in combination with other compounds or drugs.

CAS Number181225-33-2
Product NameGinsenoside RG4
IUPAC Name(2S,3R,4R,5R,6S)-2-[(2R,3R,4S,5S,6R)-2-[[(3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-3,12-dihydroxy-4,4,8,10,14-pentamethyl-17-[(2Z)-6-methylhepta-2,5-dien-2-yl]-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-6-yl]oxy]-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]oxy-6-methyloxane-3,4,5-triol
Molecular FormulaC42H70O12
Molecular Weight767 g/mol
InChIInChI=1S/C42H70O12/c1-20(2)11-10-12-21(3)23-13-16-41(8)29(23)24(44)17-27-40(7)15-14-28(45)39(5,6)36(40)25(18-42(27,41)9)52-38-35(33(49)31(47)26(19-43)53-38)54-37-34(50)32(48)30(46)22(4)51-37/h11-12,22-38,43-50H,10,13-19H2,1-9H3/b21-12-/t22-,23+,24+,25-,26+,27+,28-,29-,30-,31+,32+,33-,34+,35+,36-,37-,38+,40+,41+,42+/m0/s1
SMILESCC1C(C(C(C(O1)OC2C(C(C(OC2OC3CC4(C(CC(C5C4(CCC5C(=CCC=C(C)C)C)C)O)C6(C3C(C(CC6)O)(C)C)C)C)CO)O)O)O)O)O
Canonical SMILESCC1C(C(C(C(O1)OC2C(C(C(OC2OC3CC4(C(CC(C5C4(CCC5C(=CCC=C(C)C)C)C)O)C6(C3C(C(CC6)O)(C)C)C)C)CO)O)O)O)O)O


INQUIRY

Scan the qr codeClose
the qr code